abstract |
The present invention relates to a method for assessing the prognosis or risk of diabetes, comprising the steps of: (a) obtaining a biological sample from a subject; And (b) one or more metabolites selected from the group consisting of retinal, retinoic acid, retinyl ester, and 4-hydroxyretinoic acid in the sample And measuring the body concentration of the diabetes mellitus. |